TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27106009

Group type: EXPERIMENTAL
Intervention: edoxaban
Number of subjects: 971

Group type: COMPARATOR
Intervention: warfarin
Number of subjects: 971
Study: 25876351

Group type: EXPERIMENTAL
Intervention: Twisting acupuncture at Taichong (LR 3) for 5 minutes (30 seconds manipulation and 30 seconds interval).
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham acupuncture at Taichong (LR 3) for 5 minutes (30 seconds manipulation and 30 seconds interval).
Number of subjects: 18
Study: 22572647

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 6

Group type: COMPARATOR
Intervention: Normal sedentary lifestyle (Control)
Number of subjects: 6
Study: 20636965

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 10

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 10
Study: 17852760

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation treatment (25 hours, across 8 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 12
Study: 16000678

Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg/day)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 12093423

Group type: EXPERIMENTAL
Intervention: Insect repellant use in high-risk situations
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Body checks for ticks after leaving infested areas
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Removing ticks from pets with bare hands
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Risk factors for tick bites
Number of subjects: 1820
Study: 12198788

Group type: EXPERIMENTAL
Intervention: Literal strings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Figurative strings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonsense strings
Number of subjects: 0
Study: 7502516

Group type: EXPERIMENTAL
Intervention: ACE-inhibitor Cilacapril, taken once a day between 7.00 a.m. and 9.00 a.m.
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: Compliant patients
Number of subjects: 945
Study: 1953094

Group type: EXPERIMENTAL
Intervention: Glutamine-enriched intravenous feedings (0.57 g/kg/day, GLN)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard parenteral nutrition (STD)
Number of subjects: 20
Study: 7010893

Group type: EXPERIMENTAL
Intervention: Heparin, 5000 units every 8 hours for 14 days
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo administered as soon as possible after the fracture
Number of subjects: 130
Study: 30915569

Group type: EXPERIMENTAL
Intervention: Stepped care (SC)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Watchful waiting
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Guided self-help
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Entire SC program
Number of subjects: 156

Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 156
Study: 28610932

Group type: EXPERIMENTAL
Intervention: Automated disinfection with hydrogen peroxide <8% and silver ions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual disinfection with 0.5% sodium hypochlorite solution
Number of subjects: 0
Study: 25904755

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 312

Group type: COMPARATOR
Intervention: Vitamin D analogs
Number of subjects: 312
Study: 23393182

Group type: EXPERIMENTAL
Intervention: Insulin-resistant individuals
Number of subjects: 26

Group type: COMPARATOR
Intervention: Insulin-sensitive individuals
Number of subjects: 26
Study: 21542027

Group type: EXPERIMENTAL
Intervention: 0.2 g/kg dose of alcohol (cumulative dose 0.8 g/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 60
Study: 19244040

Group type: EXPERIMENTAL
Intervention: 3D segmentation and computerized volumetry technique
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Whole-body MR imaging
Number of subjects: 52
Study: 17578786

Group type: EXPERIMENTAL
Intervention: HIV-infected women with TB
Number of subjects: 715

Group type: COMPARATOR
Intervention: HIV-infected women without TB
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Infants of mothers with TB
Number of subjects: 715

Group type: COMPARATOR
Intervention: Infants of mothers without TB
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Women with incident TB
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Infants of women with incident TB
Number of subjects: 715
Study: 15137555

Group type: EXPERIMENTAL
Intervention: Physiotherapy intervention (low intensity, mean visits Oxford = 4, Bradford = 5)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 264
Study: 11247684

Group type: EXPERIMENTAL
Intervention: Plastic adhesive drapes
Number of subjects: 298

Group type: COMPARATOR
Intervention: No plastic adhesive drapes (control)
Number of subjects: 298
Study: 9260367

Group type: EXPERIMENTAL
Intervention: Felodipine ER (5-10 mg daily, doubled if necessary)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Atenolol (50-100 mg daily, doubled if necessary)
Number of subjects: 70
Study: 8294169

Group type: EXPERIMENTAL
Intervention: Netilmicin (100 mg dose)
Number of subjects: 62
Study: 2832287

Group type: EXPERIMENTAL
Intervention: Cyproheptadine (0.1 mg/kg body weight)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 6
Study: 29943054

Group type: EXPERIMENTAL
Intervention: Laparoscopic-guided TAP block with 20 ml of 0.25% bupivacaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard port site infiltration with 3-5 ml of 0.25% bupivacaine
Number of subjects: 90
Study: 27994001

Group type: EXPERIMENTAL
Intervention: 400 μg folic acid/day for 90 days
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: COMPARATOR
Intervention: Pre-fortification sperm DNA methylation profiles
Number of subjects: 46
Study: 25711262

Group type: EXPERIMENTAL
Intervention: air‐Q® (air‐Q)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ambu® aura‐i (aura‐i)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: i‐gel® (i‐gel)
Number of subjects: 22
Study: 23547511

Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin (PRF) applied locally (6 ml)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no PRF applied)
Number of subjects: 28
Study: 21372003

Group type: EXPERIMENTAL
Intervention: Rilonacept
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 19655334

Group type: EXPERIMENTAL
Intervention: Normal saline infusion
Number of subjects: 982

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 982

Group type: EXPERIMENTAL
Intervention: Polygeline infusion
Number of subjects: 982

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 982
Study: 17919563

Group type: EXPERIMENTAL
Intervention: Proximal protection
Number of subjects: 594

Group type: COMPARATOR
Intervention: Distal protection
Number of subjects: 594
Study: 15353455

Group type: EXPERIMENTAL
Intervention: Open venous reservoir (15 patients)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Closed venous reservoir (15 patients)
Number of subjects: 30
Study: 11872276

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (RT) 54 Gy in 6 weeks
Number of subjects: 311

Group type: COMPARATOR
Intervention: No treatment after surgery until tumor progression (Control)
Number of subjects: 311
Study: 9672056

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (nortriptyline hydrochloride)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care by primary physician
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacotherapy relative to usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 0
Study: 7601178

Group type: EXPERIMENTAL
Intervention: Topical NSAID felbinac
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral NSAIDs (ibuprofen, fenbufen)
Number of subjects: 0
Study: 2584638

Group type: EXPERIMENTAL
Intervention: General anesthesia (Group 2)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (Group 1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both types of anesthesia
Number of subjects: 20
Study: 31467314

Group type: EXPERIMENTAL
Intervention: HHR‐LNF (HHR with laparoscopic Nissen fundoplication)
Number of subjects: 122

Group type: COMPARATOR
Intervention: HHR (Hiatal hernia repair)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: HHR‐LNF
Number of subjects: 122
Study: 28737627

Group type: EXPERIMENTAL
Intervention: PHiD‐CV10 (10-valent pneumococcal conjugate vaccine)
Number of subjects: 47000

Group type: COMPARATOR
Intervention: Control vaccine
Number of subjects: 47000

Group type: EXPERIMENTAL
Intervention: PHiD‐CV10
Number of subjects: 47000
Study: 25097089

Group type: EXPERIMENTAL
Intervention: Supraclavicular block + distal median, radial, and ulnar nerve blocks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Supraclavicular block only
Number of subjects: 62
Study: 23283428

Group type: EXPERIMENTAL
Intervention: Simvastatin 3 mg/kg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Simvastatin 40 mg
Number of subjects: 10
Study: 20636448

Group type: EXPERIMENTAL
Intervention: Inpatient physiotherapy in warm climate (Spain)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inpatient physiotherapy in cold climate (Norway)
Number of subjects: 60
Study: 20077983

Group type: EXPERIMENTAL
Intervention: Modified counseling (Therapeutic Conversation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 30
Study: 16962345

Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg ex‐actuator (equivalent to 400 microg ex‐valve)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Budesonide 400 microg
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Ciclesonide
Number of subjects: 399

Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 399
Study: 14987187

Group type: EXPERIMENTAL
Intervention: Head-down tilt position during physiotherapy treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Flat side-lying position during physiotherapy treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Physiotherapy treatment (both positions)
Number of subjects: 20
Study: 11150262

Group type: EXPERIMENTAL
Intervention: Gas-filled eyes with 10% to 15% gas volume
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Gas-filled eyes with 20% gas volume
Number of subjects: 9

Group type: COMPARATOR
Intervention: Contralateral control eyes
Number of subjects: 9
Study: 9040032

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) trabeculae
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adenosine receptor stimulation (ADO) trabeculae, 125 micromol/l for 5 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhibition of K(ATP) channel with glibenclamide (GLI) trabeculae, 10 micromol/l
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adenosine pretreatment combined with glibenclamide (ADO+GLI) trabeculae
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simulated ischemia-reperfusion (I/R) trabeculae
Number of subjects: 0
Study: 8164027

Group type: EXPERIMENTAL
Intervention: GM2/BCG vaccine
Number of subjects: 122

Group type: COMPARATOR
Intervention: BCG alone
Number of subjects: 122
Study: 2500069

Group type: EXPERIMENTAL
Intervention: Group A: 20 mg of MMC on the day of surgery and 10 mg of MMC the day after surgery, started on tegafur at a dose of 600 mg/day 2 weeks after surgery
Number of subjects: 210

Group type: COMPARATOR
Intervention: Group B: similarly treated with MMC and started on UFT at a dose of 600 mg/day 2 weeks after surgery
Number of subjects: 210
Study: 1101081

Group type: EXPERIMENTAL
Intervention: Vincristine (VCR) and Prednisone (Pred)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Vincristine (VCR), Prednisone (Pred), and Daunorubicin (DNR)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: CNS prophylaxis with methotrexate, intrathecally, three times
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Vincristine and Prednisone reinduction therapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Group A (VCR and Pred)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Group B (VCR, Pred, and DNR)
Number of subjects: 73
Study: 31883905

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral approach in a dysmenorrhea support program (6 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 60
Study: 30757992

Group type: EXPERIMENTAL
Intervention: Group Attachment-Based Intervention (GABI)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Systematic Training for Effective Parenting (STEP)
Number of subjects: 78
Study: 28531872

Group type: EXPERIMENTAL
Intervention: Counter-conditioning (animal paired with a happy face)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Extinction (animal without scared face)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (no fear reduction procedure)
Number of subjects: 73
Study: 25303169

Group type: EXPERIMENTAL
Intervention: Step aerobic dance combined with upper‐body resistance training (SAR; N=15)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Traditional aerobic dance (AD; N=11)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sedentary time control (CON; N=15)
Number of subjects: 41
Study: 22821424

Group type: EXPERIMENTAL
Intervention: Green-lipped mussel extract (3,000 mg/day)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Glucosamine sulphate (3,000 mg/day)
Number of subjects: 38
Study: 16521117

Group type: EXPERIMENTAL
Intervention: Pycnogenol 30 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study: 14525804

Group type: EXPERIMENTAL
Intervention: DeVilbiss AutoAdjust LT
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: AutoSet T
Number of subjects: 29

Group type: COMPARATOR
Intervention: Fixed-pressure CPAP
Number of subjects: 29
Study: 10524414

Group type: EXPERIMENTAL
Intervention: Intraluminal brachytherapy combined with external irradiation (total of 60 Gy external + 10 Gy intraluminal brachytherapy)
Number of subjects: 94

Group type: COMPARATOR
Intervention: External irradiation alone (60 Gy)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Intraluminal brachytherapy combined with external irradiation (for tumors 5 cm or less)
Number of subjects: 94

Group type: COMPARATOR
Intervention: External irradiation alone (for tumors 5 cm or less)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Intraluminal brachytherapy combined with external irradiation (for Stage T1 and T2 disease)
Number of subjects: 94

Group type: COMPARATOR
Intervention: External irradiation alone (for Stage T1 and T2 disease)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Intraluminal brachytherapy combined with external irradiation (for Stage T3-4 disease)
Number of subjects: 94

Group type: COMPARATOR
Intervention: External irradiation alone (for Stage T3-4 disease)
Number of subjects: 94
Study: 7499713

Group type: EXPERIMENTAL
Intervention: Redeepening incisions
Number of subjects: 2

Group type: COMPARATOR
Intervention: Single pass incisions (Control)
Number of subjects: 2
Study: 1837550

Group type: EXPERIMENTAL
Intervention: Prophylactic teicoplanin (one single bolus intravenous injection before catheter insertion)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No teicoplanin (control group)
Number of subjects: 88
Study: 6124424

Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg tofisopam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 200 mg tofisopam
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31753032

Group type: EXPERIMENTAL
Intervention: EMDR therapy (nine sessions, around 60 min each, delivered weekly)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Treatment as usual (routine care)
Number of subjects: 46
Study: 27876105

Group type: COMPARATOR
Intervention: Cognition-focused (CF) intervention
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Positive psychology (PP) intervention
Number of subjects: 65
Study: 24255546

Group type: EXPERIMENTAL
Intervention: Exercise therapy and patient education
Number of subjects: 109

Group type: COMPARATOR
Intervention: Patient education only
Number of subjects: 109
Study: 23415623

Group type: EXPERIMENTAL
Intervention: Call-recall program (intervention group, 201 participants)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Usual care from the existing cervical screening program (control group, 202 participants)
Number of subjects: 403
Study: 21694601

Group type: EXPERIMENTAL
Intervention: 6‐day awareness program
Number of subjects: 344

Group type: COMPARATOR
Intervention: 1‐day awareness program
Number of subjects: 344
Study: 18448211

Group type: EXPERIMENTAL
Intervention: Live, oral ADV‐4 and ADV‐7 vaccines administered in a single dose to 30 subjects.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo administered to 28 subjects.
Number of subjects: 30
Study: 17285717

Group type: EXPERIMENTAL
Intervention: Silver nitrate ointment
Number of subjects: 120
Study: 12806612

Group type: EXPERIMENTAL
Intervention: Rectal diclofenac (100 mg)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 10741701

Group type: EXPERIMENTAL
Intervention: Irinotecan (IRN) administered by a 1-h i.v. infusion at doses of 20, 24, or 29 mg/m2 daily for 5 consecutive days for 2 weeks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irinotecan (IRN) at doses of 20, 24, and 29 mg/m2.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irinotecan (IRN) after dose 1.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irinotecan (IRN) and its metabolites.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protracted schedule of administration of Irinotecan (IRN).
Number of subjects: 0
Study: 8900703

Group type: EXPERIMENTAL
Intervention: Computer-aided learning (CAL) lessons in diabetes management
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional diabetes classes conducted by diabetes educators
Number of subjects: 36
Study: 1801155

Group type: EXPERIMENTAL
Intervention: 5 mg/kg of amocarzine once daily (12 patients)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 3 mg/kg of amocarzine twice daily (59 patients)
Number of subjects: 71
Study: 6410759

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Pergolide
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Bromocriptine or Pergolide
Number of subjects: 42
Study: 30908139

Group type: EXPERIMENTAL
Intervention: Volunteer-run patient navigation intervention
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 30309839

Group type: COMPARATOR
Intervention: Lycopene capsule (15 mg)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Lycopene-enriched diet
Number of subjects: 133

Group type: COMPARATOR
Intervention: Active capsule group (EGCG 600 mg)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Green tea drink (3 cups)
Number of subjects: 133
Study: 28206898

Group type: EXPERIMENTAL
Intervention: Fluoride varnish application
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo varnish application
Number of subjects: 200
Study: 25297016

Group type: EXPERIMENTAL
Intervention: Idalopirdine 90 mg/day (30 mg thrice daily)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Idalopirdine
Number of subjects: 278
Study: 22395120

Group type: EXPERIMENTAL
Intervention: Real-time data processing (RTP) system for cardiac output (CO) and mean arterial pressure (MAP) measurement
Number of subjects: 10

Group type: COMPARATOR
Intervention: Post hoc data processing (PP)
Number of subjects: 10
Study: 19320533

Group type: EXPERIMENTAL
Intervention: Galantamine treatment for 6 months
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Low carotid IMT
Number of subjects: 54
Study: 17462043

Group type: EXPERIMENTAL
Intervention: Bran supplement with planned nursing interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 0
Study: 16353060

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg) with Indapamide (1.25 mg) (Noliprel forte)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Captopril (50 mg) with Hydrochlorothiazide (25 mg) (Capozide)
Number of subjects: 40
Study: 11955727

Group type: EXPERIMENTAL
Intervention: Beta-interferon (Betaseron) 16 x 10(6) IU by i.v. bolus 3 days a week on Weeks 1, 3, and 5, given 30 minutes before radiation therapy.
Number of subjects: 123

Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone, 2 Gy per fraction, 5 days a week, for a total of 60 Gy over 6 weeks.
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Beta-interferon arm
Number of subjects: 123

Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 123
Study: 9708687

Group type: EXPERIMENTAL
Intervention: Paracetamol 1g
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Paracetamol 1g plus codeine 60 mg
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study: 8520076

Group type: EXPERIMENTAL
Intervention: Haloperidol decanoate (HD)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 15
Study: 2281374

Group type: EXPERIMENTAL
Intervention: Rehabilitation treatment group
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 307487

Group type: EXPERIMENTAL
Intervention: Transcutaneous nerve stimulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31331777

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine
Number of subjects: 2116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2116
Study: 28368909

Group type: EXPERIMENTAL
Intervention: Asacol 2.4 g once daily (QD) for 48 weeks
Number of subjects: 604

Group type: COMPARATOR
Intervention: Asacol 2.4 g three times daily (TID) for 48 weeks
Number of subjects: 604
Study: 26409291

Group type: EXPERIMENTAL
Intervention: Topical bevacizumab 0.05%
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 23571420

Group type: EXPERIMENTAL
Intervention: XR-NTX
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28